# Filing Detail

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001595888-26-000089
Filing Date
2026-08-10
Accepted
2026-08-10 16:39:03
Documents
2
X0202

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | primary_doc.html | SCHEDULE 13G/A |
1 |  | primary_doc.xml | SCHEDULE 13G/A | 7521
2 | POA | POA.pdf | EX-1 | 666222
| Complete submission text file | 0001595888-26-000089.txt |  | 926420

Mailing Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA
Business Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA 678-384-7220
GeoVax Labs, Inc. (Subject) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-56365 | Film No.: 261259094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 VESEY STREET 3RD FLOOR NEW YORK NY
Business Address 250 VESEY STREET 3RD FLOOR NEW YORK NY 212-651-6069
JANE STREET GROUP, LLC (Filed by) CIK: 0001595888 (see all company filings)

EIN.: 901010033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A